Lab News
Bristol Myers Squibb promotes ctDNA liquid biopsy study
May 18, 2022 -- Bristol Myers Squibb (BMS) is highlighting results from a research study on circulating tumor DNA (ctDNA) liquid biopsy published April 28 in PLOS ONE. Read More
Proscia unveils QC tool, new version of research platform
May 18, 2022 -- Digital pathology software developer Proscia has unveiled an automated quality-control (QC) software application and a new version of its Concentriq for Research platform. Read More
Intermountain Healthcare to offer Galleri cancer blood test
May 18, 2022 -- Utah-based health system Intermountain Healthcare will be offering Grail’s Galleri multicancer early detection blood test as a complement to existing single-cancer screenings. Read More
Diadem highlights new study on AlzoSure test for Alzheimer's
May 18, 2022 -- Diadem is directing attention to new research that found its AlzoSure Predict blood test outperformed amyloid PET imaging in predicting progression to Alzheimer’s disease up to six years before diagnosis. Read More
Quidel shareholders approve $6B deal to buy Ortho
May 17, 2022 -- Quidel shareholders have approved the company's deal to buy Ortho Clinical Diagnostics. The acquisition is expected to close on May 27. Read More
LabConnect names pharma industry vet Sherman as CEO
May 17, 2022 -- Laboratory services provider LabConnect has named Dawn Sherman as the company's CEO. Sherman is an experienced executive in the pharmaceutical industry, with previous stints at ProPharma Group, EnvisionRxOptions, and Teva Pharmaceuticals. Read More
Accelerate commercializes blood culture kit
May 16, 2022 -- Accelerate Diagnostics is commercializing its Accelerate Arc and BC (blood culture) kit, a rapid microbial identification system for positive blood cultures. Read More
FDA OKs Labcorp's over-the-counter COVID-19, RSV, flu test
May 16, 2022 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Labcorp for the first nonprescription test that can detect COVID-19, respiratory syncytial virus (RSV), and influenza A and B. Read More
Artemis signs $250M deal for liquid biopsy tests with Datar
May 16, 2022 -- Diagnostic laboratory Artemis DNA has signed a $250 million deal to offer new cancer liquid biopsy tests through oncology diagnostics developer Datar Cancer Genetics. Read More
Qiagen expands QIAstat-Dx syndromic panel
May 16, 2022 -- Qiagen has launched QIAstat-Dx Rise, a high-capacity version of the QIAstat-Dx automated syndromic system. The company has also released enhancements to its QIAstat-Dx menu of tests. Read More
American Diabetes Association (ADA) Scientific Sessions
June 3-7
New Orleans, Louisiana United States
American Society of Clinical Oncology Annual Meeting
June 3-7
Chicago, Illinois United States
International Liver Congress
June 22-26
London United Kingdom
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets